ES71
TEAS SECTION 71 RECEIVED
30/06/2026
Voltar para busca
Dado oficial do USPTO
PHARA PHARMACEUTICAL REGULATORY AFFAIRS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
01/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35
Data de depósito
21/12/2018
Data de registro
30/06/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/06/2020
Última transação
01/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
68
Localização do titular
BE
Examinador
BIACHE, AUBREY
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "PHARA" in red above the stylized wording "PHARMACEUTICAL REGULATORY AFFAIRS" in red.
Titulares e representantes
Titulares
PhaRA Holding, besloten vennootschap metbeperkte aansprakelijkheid
Representantes
Andrew T. Rissler Patel IP, P.C.
Classificação técnica
Classes Nice
Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business administrative consultancy with regard to the submission of New Drug Applications (NDAs) to the United States Food and Drug Administration (FDA) and Marketing Authorisation Applications (MMAs) to the EMA; business administrative services for the registration of physiciansinvestigations and research methods in the field of medicineupdating and maintenance of information in registries; interim business management; personnel placement and recruitment; Employment recruiting servicesassistance relating to recruitment and placement of staff; consultancy with regard to personnel recruitment; personnel selection using psychological testing; psychological testing for the selection of personnel for the purposes of assessing professional expertise; Employment recruiting consultationassessment of personnel requirements; provision of commercial and business contact informationcommercial mediation in establishing business contacts between applicants and providers of medical services; lobbying for commercial purposes related to the medical and the pharmaceutical sectors by consulting with care providers in order to be able to provide the necessary customized care; organisation of events for advertising and/or commercial purposes; compilation of data files into computer databases and database management of data files; mediation and conclusion of commercial transactions for othersmediation in the establishment of business contactsincluding in the context of medical and pharmaceutical services; the aforesaid services also provided via telecommunications channelsincluding the internet; commercial-business advice for the business management of a hospital and/or clinic; consultancy regarding business organisation and business economics; business administration services; business administrative servicesproviding office functions; business management; business organizationbusiness economics being business information and business assistance services during commercialization and business management of a clinicmedical center being a franchise; psychological testing for the selection of personnel; professional business consultancy
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
30/06/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/01/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
22/10/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
22/10/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/09/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
30/06/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/04/2020
PUBO
PUBLISHED FOR OPPOSITION
14/04/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/03/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/03/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/03/2020
GNFR
FINAL REFUSAL E-MAILED
10/03/2020
CNFR
FINAL REFUSAL WRITTEN
10/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/02/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/02/2020
RFNT
REFUSAL PROCESSED BY IB
20/09/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/09/2019
RFRR
REFUSAL PROCESSED BY MPU
05/09/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/08/2019
CNRT
NON-FINAL ACTION WRITTEN
20/08/2019
MAFR
APPLICATION FILING RECEIPT MAILED
06/08/2019
DOCK
ASSIGNED TO EXAMINER
31/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/07/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
27/07/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/07/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PHARA PHARMACEUTICAL REGULATORY AFFAIRS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.